T-REX

T-REX is a St. Louis-based accelerator supporting early-stage technology and innovation companies, with healthcare exposure spanning digital health and medical devices. As an accelerator rather than a traditional venture fund, T-REX provides a combination of small initial capital, workspace, mentorship, and ecosystem access. Limited public information is available on dedicated healthcare staff or a deep specialty thesis, and health-related companies appear to be supported within the broader accelerator program rather than through a vertical-specific track. Founders should view T-REX as community and infrastructure support more than primary venture capital.

Check sizes are typically under two hundred and fifty thousand dollars at pre-seed and seed stages, often paired with the non-cash benefits of accelerator participation. The organization operates from St. Louis with primary focus on Missouri and Midwest founders, providing local ecosystem access in a market where venture infrastructure is more limited than in coastal hubs. Stage focus means T-REX is most useful for very early companies that benefit from structured support, mentorship, and community alongside small initial capital, rather than for companies seeking primary lead investors.

For founders, T-REX is most relevant to early-stage digital health and medical device teams based in or willing to operate from St. Louis. Strong operating execution, willingness to engage with the local ecosystem and mentor network, and realistic expectations about the role of an accelerator in a broader fundraise will all matter. Companies pursuing capital-intensive biotech or therapeutics will not align with the program’s structure. Founders should pair T-REX participation with later commitments from primary venture leads, since the accelerator is best understood as a launching point rather than a complete capital solution.